Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (243)	1/29/1998 5:31:00 PM
From: Peter Silsbee	Read Replies (1) of 1494

Another trial result: Neurobiological Technologies, Inc. Announces Publication of Phase I/II Xerecept(TM)Trial Results biz.yahoo.com Finally some positive CRF results! Though it's hard to get too excited about statements like "the data suggest that Xerecept has the potential to be at least as effective as the current standard treatment for the condition." I know, they have to sound wishy-washy so they don't get sued... Larger Phase I/II study is already in progress. PLS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next